Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells - 29/02/24

Abstract |
Proinsulin C-peptide, a biologically active polypeptide released from pancreatic β-cells, is known to prevent hyperglycemia-induced microvascular leakage; however, the role of C-peptide in migration and invasion of cancer cells is unknown. Here, we investigated high glucose-induced migration and invasion of ovarian cancer cells and the inhibitory effects of human C-peptide on metastatic cellular responses. In SKOV3 human ovarian cancer cells, high glucose conditions activated a vicious cycle of reactive oxygen species (ROS) generation and transglutaminase 2 (TGase2) activation through elevation of intracellular Ca2+ levels. TGase2 played a critical role in high glucose-induced ovarian cancer cell migration and invasion through β-catenin disassembly. Human C-peptide inhibited high glucose-induced disassembly of adherens junctions and ovarian cancer cell migration and invasion through inhibition of ROS generation and TGase2 activation. The preventive effect of C-peptide on high glucose-induced ovarian cancer cell migration and invasion was further demonstrated in ID8 murine ovarian cancer cells. Our findings suggest that high glucose conditions induce the migration and invasion of ovarian cancer cells, and human C-peptide inhibits these metastatic responses by preventing ROS generation, TGase2 activation, and subsequent disassembly of adherens junctions.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | High glucose conditions activated a vicious cycle of ROS generation and TGase2 activation. |
• | TGase2 played a critical role in high glucose-induced ovarian cancer cell migration and invasion. |
• | C-peptide attenuated these metastatic responses by inhibiting the vicious cycle. |
• | C-peptide is a potential inhibitor of hyperglycemia-induced ovarian cancer metastasis. |
Abbreviations : BAPTA-AM, DM, FBS, FITC, H2DCFDA, MDC, NAC, ROS, TGase2, VEGF
Keywords : C-peptide, High glucose, Invasion, Migration, Ovarian cancer, Transglutaminase 2
Plan
Vol 172
Article 116232- mars 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?